Skip to content

Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD)

Effectiveness and Neuropsychological Predictors of Guided Self-Help for OCD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01659125
Enrollment
26
Registered
2012-08-07
Start date
2012-08-31
Completion date
2014-06-30
Last updated
2016-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder

Brief summary

The primary aim of this study is to learn about who is most likely to benefit from guided self-help (GSH) for obsessive-compulsive disorder (OCD).

Detailed description

40 Participants with OCD will be recruited. They will be given access to OC Fighter, an internet OCD treatment program. During the 17 week program, participants will meet with a therapist 9 times. Assessments will occur at pretreatment, post-treatment, 3-month follow up and 6-month follow up.

Interventions

BEHAVIORALOCFighter

OCFighter™ s an interactive, internet guided self-help (GSH) treatment program for obsessive-compulsive disorder (OCD). It uses the evidence based approach known as Cognitive Behavioral Therapy (CBT) and was adapted from the previously validated BT STEPS program for OCD. The program teaches the best practice CBT technique to help with OCD called exposure with ritual prevention (ERP).

Sponsors

Hartford Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Principal or co-principal diagnosis of OCD * Clinical global impression score greater than or equal to 4 * Y-BOCS score great than or equal to 8 * Fluency in English * Capacity to understand the nature of the study and willingness to sign informed consent form

Exclusion criteria

* Active manic episode, psychosis, pervasive developmental disorder, mental retardation * Concurrent OCD psychotherapy * Current threat of harm to self or others * Previous adequate trial of therapist-administered or self-administered exposure and response prevention for OCD

Design outcomes

Primary

MeasureTime frameDescription
Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)Baseline (pretreatment), 17-weeks (posttreatment), and 6 month-follow-upThe Y-BOCS is a semi-structured interview that assesses severity of obsessions and compulsions. The total score is reported here and ranges from 0 to 40 with higher scores indicating more severe OCD symptoms.
Responder StatusWeek 17 (post-treatment) and 6-month follow-upParticipants who experienced a clinically significant change in Y-BOCS score defined as posttreatment YBOCS score that (a) has decreased by a reliable level (at least 1.96 times the standard deviation of that measure, taking into account the reliability of the measure itself; in this case, a decrease of 5 points or more), and (b) is within the nonclinical range of scores (in this case, a score of 13 or below).

Countries

United States

Participant flow

Participants by arm

ArmCount
OCFighter Participants
OCFighter OCFighter: OCFighter™ s an interactive, internet guided self-help (GSH) treatment program for obsessive-compulsive disorder (OCD). It uses the evidence based approach known as Cognitive Behavioral Therapy (CBT) and was adapted from the previously validated BT STEPS program for OCD. The program teaches the best practice CBT technique to help with OCD called exposure with ritual prevention (ERP).
26
Total26

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyFailed to Start Treatment2
Overall StudyLost to Follow-up7
Overall StudyTechnical Problem1
Overall StudyTime Constraints2
Overall StudyWithdrawal by Subject2

Baseline characteristics

CharacteristicOCFighter Participants
Age, Continuous37.08 years
STANDARD_DEVIATION 12.57
Region of Enrollment
United States
26 participants
Sex: Female, Male
Female
17 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 24
serious
Total, serious adverse events
1 / 24

Outcome results

Primary

Change in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)

The Y-BOCS is a semi-structured interview that assesses severity of obsessions and compulsions. The total score is reported here and ranges from 0 to 40 with higher scores indicating more severe OCD symptoms.

Time frame: Baseline (pretreatment), 17-weeks (posttreatment), and 6 month-follow-up

Population: Results are reported at each time-point for the intent-to-treat sample of participants who initiated treatment (n = 24).

ArmMeasureGroupValue (MEAN)Dispersion
OCFighter ParticipantsChange in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)Baseline (pre-treatment)24.67 units on a scaleStandard Deviation 5.16
OCFighter ParticipantsChange in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)week 17 (post-treatment)18.29 units on a scaleStandard Deviation 9.06
OCFighter ParticipantsChange in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)6-month Follow-up18.46 units on a scaleStandard Deviation 7.79
Primary

Responder Status

Participants who experienced a clinically significant change in Y-BOCS score defined as posttreatment YBOCS score that (a) has decreased by a reliable level (at least 1.96 times the standard deviation of that measure, taking into account the reliability of the measure itself; in this case, a decrease of 5 points or more), and (b) is within the nonclinical range of scores (in this case, a score of 13 or below).

Time frame: Week 17 (post-treatment) and 6-month follow-up

Population: Results are reported at each time-point for the intent-to-treat sample of participants who initiated treatment (n = 24).

ArmMeasureGroupValue (NUMBER)
OCFighter ParticipantsResponder StatusWeek 17 (post-treatment)5 participants
OCFighter ParticipantsResponder Status6- Month follow-up5 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026